Table 1.
Patient ID | Chr | Gene | cDNA change | AA change | Mutation type | REF | ALT | ExAC_pLI | SITF | Polyphen2 | CADD | ExAC | 1000G | gnomAD |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AIS1188 | 6 | ESR1 | c.868A>G | p.Asn290Asp | Missense | A | G | 0.99 | T | P | 13.47 | 0 | 0 | 0 |
AIS80 | 14 | ESR2 | c.236T>C | p.Leu79Ser | Missense | T | C | 0 | D | P | 10.51 | 0 | 0 | 0.0001 |
Chr – chromosomal localization; cDNA change – nucleotide change; AA change – amino acid change; REF – the reference allele; ALT – the alternative allele; ExAC_pLI – the probability of being loss-of-function intolerant (pLI) score from Exome Aggregation Consortium (ExAC); SIFT – sorting intolerant from tolerant; PolyPhen-2 – polymorphism phenotyping v2; CADD – Combined Annotation Dependent Depletion; T – tolerated; D – deleterious; damaging, P – possibly damaging; Public data base (ExAC_HomoAlt, 1000G_ALL and gnomAD_genome_ALL).